vTv Therapeutics (FRA:5VT0) Dividends per Share: €0.00 (TTM As of Mar. 2026)

What is vTv Therapeutics Dividends per Share?

vTv Therapeutics FRA:5VT0 +1.37% 35 Dividends per Share is €0.00 as of Mar. 2026. GuruFocus rates FRA:5VT0 with a GF Score™ of 35/100 and a GF Value™ of €6,924.34.

vTv Therapeutics's dividends per share for the three months ended in Mar. 2026 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2026 was 0.00. As of today, vTv Therapeutics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

vTv Therapeutics (FRA:5VT0) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

vTv Therapeutics's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2026 )	/	EPS without NRI (Q: Mar. 2026 )
	=	0	/	1.427
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

vTv Therapeutics Dividends per Share Related Terms

vTv Therapeutics Dividends per Share Historical Data

* Premium members only.

The historical data trend for vTv Therapeutics's Dividends per Share can be seen below:

vTv Therapeutics Dividends per Share Chart

vTv Therapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Dividends per Share

Get a 7-Day Free Trial

0.00

vTv Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Dividends per Share	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

FRA:5VT0 vs SMNR, CNTB, ENLV: Dividends per Share Comparison

For the Biotechnology subindustry, vTv Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

vTv Therapeutics Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, vTv Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where vTv Therapeutics's Dividend Yield % falls into.

Save Embed

35GF Score

vTv Therapeutics Inc FRA:5VT0

Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

vTv Therapeutics Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →

What does a Dividends per Share of €0.00 mean?

vTv Therapeutics (FRA:5VT0) has a Dividends per Share of €0.00 as of Mar. 2026. Dividends per share represents the per-share amount paid as dividends. View historical data on vTv Therapeutics and its competitors.

Is vTv Therapeutics' Dividends per Share too high?

vTv Therapeutics' current Dividends per Share is €0.00. Overall, vTv Therapeutics has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.

How does vTv Therapeutics' Dividends per Share compare to SMNR and CNTB?

vTv Therapeutics' Dividends per Share of €0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividends per Share for a Biotechnology company?

A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividends per Share mean?

A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on vTv Therapeutics and its competitors. vTv Therapeutics's current Dividends per Share is €0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is vTv Therapeutics stock overvalued right now?

vTv Therapeutics (FRA:5VT0) has a current Dividends per Share of €0.00. The stock's GF Value™ is €6,924.34, compared to a current price of €29.60 — trading 99.6% below its estimated fair value. The current Dividends per Share is €0.00. vTv Therapeutics' overall GF Score™ is 35/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividends per Share calculated?

Dividends per Share is calculated from a company's financial statements. For vTv Therapeutics (FRA:5VT0), the current Dividends per Share is €0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is vTv Therapeutics (FRA:5VT0) Overvalued in 2026?

Based on GuruFocus' analysis, vTv Therapeutics stock appears to be undervalued. The current stock price of €29.60 is trading 99.6% below its estimated GF Value™ of €6,924.34.

Key valuation signals for FRA:5VT0:

Dividends per Share: €0.00
GF Value™: €6,924.34 vs. price of €29.60 (99.6% below fair value)
GF Score™: 35/100

No single metric tells the full story. See the FRA:5VT0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

vTv Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies SMNR CNTB ENLV MENS SPRO VXRT ACOG HURA ADCT GNLX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges VTVT:USA

Address 3980 Premier Drive, Suite 110, High Point, NC, USA, 27265

Website https://www.vtvtherapeutics.com

vTv Therapeutics Inc is a late-stage biopharmaceutical company focused on developing oral, small-molecule drug candidates intended to help treat people living with diabetes and other chronic diseases. Its clinical pipeline is led by cadisegliatin (TTP399), a novel, small-molecule, liver-selective glucokinase activator (GKA) currently being evaluated as a potential oral adjunctive therapy to insulin for the treatment of type 1 diabetes (T1D). In addition, the company is also engaged in the research and development of other candidates in its pipeline through collaborations with academic partners and license agreements, which include TTP273, HPP737, TTP-RA, Mavodelpar (HPP593), HPP971, and HPP3033, being studied and developed to counter various chronic diseases.

35GF Score

Get the complete analysis for FRA:5VT0

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€29.60

Price

€6,924.34

GF Value

View FRA:5VT0 Analysis

See Dividends per Share data for all stocks →